← Scoopfeeds — Intelligent news, curated.
international

Abivax shares jump 36% as new trial data support ulcerative colitis drug obefazimod

Euronews · Jun 30, 2026, 12:59 PM · Also reported by 2 other sources

Why this matters: an international story with cross-border implications worth tracking.

French biotech company Abivax said new clinical trial data supports the safety and effectiveness of its experimental ulcerative colitis treatment.

Read full story on Euronews → More top stories

Also covered by

Investing.com Moleculin reports positive interim data from AML trial Investing.com Guggenheim reiterates Abivax stock rating on cancer data

More in international

Euronews
Italy’s luxury portfolio expands with new openings from Hyatt, IHG and Dior Spa
DW English
Swift Boost Mission: An opportunity for science and defense
The Hindu
YSRCP accuses government of plans to privatise RTC depot lands
The Hindu
Families appeal for rescue of five fishermen stranded in Somalia
The Hindu
Livelihood pressures, participation fatigue key reasons for low gram sabha attendance: study

Browse all international coverage →

Aggregated and edited by the Scoop newsroom. We surface news from Euronews alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop